NL-OMON35953已完成不适用
Tumor profiling in pancreatic carcinoma, a multidisciplinary initiative - Pancreas bio bank project
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Suspicion of potentially resectable and irresectable pancreatic malignancy on preoperative imaging
排除标准
- •Not able to give informed consent
研究者
相似试验
已完成
不适用
Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic TumorsPancreatic TumorNCT01692873Institut Paoli-Calmettes274
Unknown
2 期
A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer.Unresectable Locally Advanced Pancreatic CancerNCT05346146RenJi Hospital20
招募中
不适用
PanDPI-Study (pancreatic carcinoma) and CoRDPI-Study (colorectal cancer)C25C18C20C78.7Malignant neoplasm of pancreasMalignant neoplasm of colonMalignant neoplasm of rectumSecondary malignant neoplasm of liver and intrahepatic bile ductDRKS00031431Klinik am See300
尚未招募
不适用
Pancreatic Cancer Surveillance in CDKN2A and Other High Risk Mutation CarriersPancreatic cancerNL-OMON27120eiden University Medical Center280
已完成
不适用
Pancreatic cancer surveillance in CDKN2A and other high risk mutation carriers'p16-Leiden'pancreatic malignancy1002766410017991NL-OMON50801eids Universitair Medisch Centrum280